Aims and Scope: Integrative Biomedical Research  is an, international, peer-reviewed, Open Access journal that publishes research and review articles on following topics:

• Molecular & Cellular Biomedicine
• Pharmacology & Drug Discovery
• Clinical & Translational Medicine
• Bioinformatics & Computational Biology
• Public Health & Epidemiology
• Biomedical Engineering & AI in Healthcare
• Natural Products & Pharmacognosy

(N.B. The journal was previously published under the title Journal of Angiotherapy.)

Integrative Biomedical Research welcomes the submission of original research articles, reviews, data reports, case studies, clinical trials, and brief communications that present significant, novel findings and advance knowledge within the realm of integartive biomedical research areas.

All accepted manuscripts are published continuously and made freely available online immediately upon publication. This open-access model ensures unrestricted access to research, facilitating widespread dissemination and engagement within the scientific community.

Integrative Biomedical Research is committed to being a valuable resource for researchers, scientists, and clinicians aiming to expand the boundaries of knowledge in integrative fields.

Peer-Review Process (please see detials in peer review policy and publishing policies)

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single-blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

• advances scientific knowledge;

• advances translational research;

• provides an adequate and relevant literature review;

• utilizes scientifically solid, reliable, and reproducible methodologies;

• derives appropriate and justifiable conclusions based upon the experimental data presented; and

• is written in English and is of the utmost quality and clarity.

Read Scope detials:

• Molecular & Cellular Biomedicine — core biomedical science; matches your existing sections (Cell and Developmental Biology, Molecular Physiology, Biomedical sciences).
• Pharmacology & Drug Discovery — directly matches your strongest existing cluster (Drug Delivery, Drug Synthesis, Clinical Pharmacology, Computational Pharmacology, Molecular and Clinical Pharmacology) — this is clearly where most of your actual content sits, so it should be a headline category, not buried.
• Clinical & Translational Medicine — matches Cardiovascular Medicine, Infectious Disease Pathogenesis, Metabolism and Biochemistry, Immunology — the applied/clinical side of your existing list.
• Bioinformatics & Computational Biology — matches AI in Biomedical Research, AI/ML/DL, Biostatistical Modeling, Computational Biology — a coherent modern subfield, increasingly common and well-regarded by indexers, not a stretch.
• Public Health & Epidemiology — matches Public Health, Infectious Disease Pathogenesis (partially) — legitimate if you actually publish in this space; if you have few/no articles here, consider folding it under Clinical & Translational Medicine instead rather than keeping it standalone.
• Biomedical Engineering & AI in Healthcare — matches Biomedical Image Analysis, Health Informatics, Information Technology (biomedical applications only) — reasonable, and it's where "AI in Biomedical Research" naturally belongs instead of floating as its own vague category.
• Natural Products & Pharmacognosy — matches Drugs from Natural Sources, Traditional and Herbal Medicine, Natural Products, Natural Drug Development — this is a well-established, real subfield in biomedical/pharma journals, not off-topic.